Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2024

Stockholders' Equity

Schedule of components of stock-based compensation included in net loss

	For the Years ended
	December 31,
	2024		2023
Employee stock options	$	837,881	$	1,929,665
Non-employee stock options		188,831		563,415
Employee stock awards		7,006		135,095
Non-employee stock awards		—		101
	$	1,033,718	$	2,628,276

Schedule of stock option activity

		Weighted				Weighted
		Average		Aggregate		Average
		Exercise		Intrinsic		Remaining
	Shares	Price		Value		Contractual Life
Stock options outstanding at December 31, 2022	66,515	$	374.98	$	16,842
Expired	(987)		1,249.50
Forfeited	(1,968)		573.65
Stock options outstanding at December 31, 2023	63,560	$	355.25	$	9,052
Expired	(1,053)		1,541.96
Forfeited	(191)		479.77
Stock options outstanding and expected to vest at December 31, 2024	62,316	$	334.82	$	6,737	6.9	Years
Stock options exercisable at December 31, 2024	57,750	$	341.03	$	6,737	6.8	Years

Schedule of restricted stock activity

		Weighted
		Average
	Shares	Fair Value
Restricted stock at December 31, 2022	170	$	644.00

Vested	(170)	644.00
Restricted stock at December 31, 2023	—	—

Schedule of RSU activity

		Weighted
		Average
	Shares	Fair Value
RSUs at December 31, 2022	—	$	—
Granted	1,800		236.00
Vested	(550)		236.00
RSUs at December 31, 2023	1,250		236.00
Vested	(50)		236.00
Cancelled	(1,200)		236.00
RSUs at December 31, 2024	—		—